InMS: Chronic insomnia disorder in multiple sclerosis – a Portuguese multicentre study on prevalence, subtypes, associated factors and impact on quality of life

Viana, Pedro; Rodrigues, Elsa; Fernandes, Carina; Matas, Andreia; Barreto, Rui; Mendonça, Marcelo; Peralta, Ana Rita; Geraldes, Ruth

doi:10.1016/j.msard.2015.07.010

Cited by 31 publications

(38 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…There are no studies focused on COI; however, Portugal is often analyzed within international studies (48). Other studies looked at several problems associated with the disease, such as sleep disturbances (75).…”

Section: % Of Patientsmentioning

confidence: 99%

Living with Multiple Sclerosis in Europe: Pharmacological Treatments, Cost of Illness, and Health-Related Quality of Life Across Countries

Gitto

2017

Multiple Sclerosis: Perspectives in Treatment and Pathogenesis

View full text Add to dashboard Cite

More than 700,000 people suffer from multiple sclerosis (MS) in Europe. This implies that more than 1 million people are affected by this disease through their role as caregivers and family members. Given its relevant impact, MS deserves consideration by epidemiologists, clinicians, psychologists, social scientists and other scholars. Such interdisciplinarity is stressed in the present contribution, which focuses on various aspects of socioeconomic burden. Starting from considerations about the epidemiology of the disease in Europe, as outlined by the MS Barometer, a comparative survey based on data collected by the national MS societies and launched in 2008, a brief literature review for each European country mentioned in the report was carried out with the following key terms: "multiple sclerosis," "cost of illness," and "health-related quality of life (HRQoL)." The consideration of the level of assistance provided, the access to rehabilitation centers, and the availability of pharmacological treatments, Drugs, Costs and Quality of Life for MS Patients in Europe 18especially innovative therapies, reveal how there are still huge differences across Europe. Literature contributions are mostly oriented toward HRQoL studies and the impact of new pharmacological treatments. There are less studies focusing on compliance: this may be the consequence of a higher awareness of the disease among the patients and a strengthened cooperation with the physicians. Some suggestions about foreseeable and desirable lines of research conclude the contribution.

show abstract

Section: % Of Patientsmentioning

confidence: 99%

Living with Multiple Sclerosis in Europe: Pharmacological Treatments, Cost of Illness, and Health-Related Quality of Life Across Countries

Gitto

2017

Multiple Sclerosis: Perspectives in Treatment and Pathogenesis

View full text Add to dashboard Cite

show abstract

“…One study found that 22% of individuals with multiple sclerosis met diagnostic criteria for insomnia disorder;(5) however, rates in patients with spinal cord injuries are not known. Some studies suggest that insomnia may contribute to depression and poor quality of life (6).…”

Section: Overview Of Sleep Disturbances In Individuals With Spinal Comentioning

confidence: 99%

Sleep-Disordered Breathing and Spinal Cord Injury: Challenges and Opportunities

Sankari

Martin

Badr

2017

Curr Sleep Medicine Rep

View full text Add to dashboard Cite

Purpose of review This paper focuses on the sleep disorders in patients with spinal cord injury (SCI/D), particularly mechanism of sleep disordered breathing (SDB) and challenges in diagnosis and management. Based on a review of recent literatures and studies the paper summarizes some main challenges with respect to management of SDB in patients with SCI; and what are the responsible mechanisms of disease? What are the barriers in diagnosing and treating SDB using standard treatment such as positive airway pressure (CPAP)?. Recent findings Previous studies have shown that most SCI/D patients have SDB with heterogeneity in prevalence mainly related to using different definition or methods of diagnosing SDB, while recent studies using new definition of SDB based on recommended criteria from the American Academy of Sleep Medicine (AASM) and also include the data on effect of SCI/D level on prevalence and describe different type of SDB. Furthermore, recent data describes simplified method of diagnosing SDB by using a combination of home sleep apnea testing and transcutaneous CO2 monitoring. Finally, emerging data has been pointing at strong relationship between SDB and cardiovascular disease including nocturnal hypertension in patients with SCI/D. Summary The findings indicate that early testing for SDB and associated cardiovascular disease in patients with SCI is recommended and could be beneficial in reduced the high morbidity and mortality in this group of patients with disability. In addition, studies on treatment of other sleep disorders in SCI/D are not available to inform clinical decision making. Understanding the pathophysiology of sleep disorders in SCI/D is critical for the development of new effective therapies. This review provides evidence for best practices; highlights new discoveries for the diagnosis and management of sleep disorders in SCI/D, and discuss challenges and future directions.

show abstract

“…A qualidade de sono ruim na EM poderia ser atribuída a diversos fatores, como a insônia, a síndrome das pernas inquietas, noctúria, depressão, ansiedade e fadiga 11 .…”

Section: Figura 1 A: Correlação Deunclassified

“…Mais de 60% dos indivíduos com EM apresentam qualidade de sono ruim10, e cerca de 23% apresentam insônia, a qual é mais prevalente em mulheres e naqueles indivíduos com alto nível de ansiedade, depressão e fadiga 11 .…”

unclassified

“…Os problemas de sono costumam estar associados à fadiga 4 , ainda que poucos autores tenham distinguido em qual aspecto da fadiga, se físico, cognitivo ou psicossocial 12 . Considerando o grande impacto destes dois fatores, fadiga e sono na qualidade de vida de indivíduos com EM 11 , e a possibilidade da perpetuação de um ciclo vicioso, o presente estudo visou: 1) avaliar a relação entre a qualidade de sono e os diferentes domínios da fadiga em indivíduos com EM; 2) descrever o padrão de sono, sonolência diurna e siesta e 3) correlacionar a fadiga com outros fatores, como tempo de diagnóstico e número de surtos.…”

unclassified

See 1 more Smart Citation

Qualidade De Sono E Sua Relação Com Fadiga Em Indivíduos Com Esclerose Múltipla

Luteski¹,

Brandalize²,

Rossi³

et al. 2017

Cad Edu Saude e Fis

View full text Add to dashboard Cite

Introdução: Oitenta por cento dos indivíduos com Esclerose Múltipla (EM) apresentam fadiga, a qual costuma ser um dos sintomas mais debilitantes. Além disso, problemas relacionados ao sono também são comuns nesses indivíduos. Objetivo: Verificar a relação entre qualidade de sono e fadiga em indivíduos com EM. Método: Dez indivíduos de ambos os sexos com idade média de 35.0 ± 8.77 anos com diagnóstico de EM do tipo remitente-recorrente e que apresentavam fadiga pela escala de severidade da fadiga (≥28) participaram do estudo. Os instrumentos utilizados foram o Índice de Qualidade do Sono de Pittsburgh (IQSP) e Escala Modificada de Impacto da Fadiga (MFIS), a qual avalia os efeitos da fadiga nas funções físicas, cognitivas e psicossociais. A duração de sono, a siesta e sonolência diurna foram obtidos através do auto-relato. Resultados: 70% dos participantes apresentaram qualidade de sono ruim (IQSP >5), as médias de duração de sono foram maiores nos finais de semana (9,6h) quando comparados aos dias de semana (7,8h). Todos os participantes relataram sonolência diurna e 90% relataram o hábito da siesta. Não houve correlação entre qualidade de sono e o escore total da fadiga (MFIS) (r=0.23, p=0.51), porém foi observada correlação entre qualidade de sono e o dominio fadiga psicossocial (r=0,69, p=0,026). Conclusão: Não houve correlação entre qualidade de sono e escore de fadiga total, entretanto, as formas de compensação do sono como a siesta podem ter influenciado nesse resultado. Contudo, houve correlação moderada entre qualidade de sono e fadiga psicossocial.

show abstract

InMS: Chronic insomnia disorder in multiple sclerosis – a Portuguese multicentre study on prevalence, subtypes, associated factors and impact on quality of life

Cited by 31 publications

References 33 publications

Living with Multiple Sclerosis in Europe: Pharmacological Treatments, Cost of Illness, and Health-Related Quality of Life Across Countries

Living with Multiple Sclerosis in Europe: Pharmacological Treatments, Cost of Illness, and Health-Related Quality of Life Across Countries

Sleep-Disordered Breathing and Spinal Cord Injury: Challenges and Opportunities

Qualidade De Sono E Sua Relação Com Fadiga Em Indivíduos Com Esclerose Múltipla

Contact Info

Product

Resources

About